Be a Smart Investor
Thursday, October 25, 2018
Eyes On Imprimis...
Shares of Imprimis Pharmaceuticals Inc. (IMMY) have returned more than 110% year-to-date while the iShares Nasdaq Biotechnology ETF (IBB) has fallen 4% during the same period.
from RTT - Biotech https://ift.tt/2yYuw4S
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment